Abstract
Tissue engineering strategies are being used to develop functional 3D heart muscle in vitro. Work within our own group has been focused on the development of bioengineered heart muscle using fibrin gel as a support matrix. As tissue engineering models of heart muscle are developed in the laboratory, a critical technologic challenge remains the ability to delivery nutrients to the entire tissue construct. To address this specific need, we have developed a novel perfusion system for cardiac tissue engineering applications. The system consists of a custom microincubator, designed to house ten 35-mm tissue culture plates on independent platforms for controlled fluid delivery and aspiration. Temperature, pH, and media flow rate and oxygenation are all regulated. In the current study, we describe the compatibility of this microperfusion system with bioengineered heart muscles. We demonstrate that the perfusion system is capable of supporting construct viability (mitochondrial activity, total protein, and total RNA) and maintaining contractile properties (twitch force, specific force, and electrical pacing). ASAIO Journal 2008; 54:284-294.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 284-294 |
| Number of pages | 11 |
| Journal | ASAIO Journal |
| Volume | 54 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2008 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Biophysics
- Biomaterials
- Bioengineering
- Biomedical Engineering
- Medicine(all)
Cite this
Development of a microperfusion system for the culture of bioengineered heart muscle. / Hecker, Louise; Khait, Luda; Radnoti, Desmond; Birla, Ravi.
In: ASAIO Journal, Vol. 54, No. 3, 05.2008, p. 284-294.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Development of a microperfusion system for the culture of bioengineered heart muscle
AU - Hecker, Louise
AU - Khait, Luda
AU - Radnoti, Desmond
AU - Birla, Ravi
PY - 2008/5
Y1 - 2008/5
N2 - Tissue engineering strategies are being used to develop functional 3D heart muscle in vitro. Work within our own group has been focused on the development of bioengineered heart muscle using fibrin gel as a support matrix. As tissue engineering models of heart muscle are developed in the laboratory, a critical technologic challenge remains the ability to delivery nutrients to the entire tissue construct. To address this specific need, we have developed a novel perfusion system for cardiac tissue engineering applications. The system consists of a custom microincubator, designed to house ten 35-mm tissue culture plates on independent platforms for controlled fluid delivery and aspiration. Temperature, pH, and media flow rate and oxygenation are all regulated. In the current study, we describe the compatibility of this microperfusion system with bioengineered heart muscles. We demonstrate that the perfusion system is capable of supporting construct viability (mitochondrial activity, total protein, and total RNA) and maintaining contractile properties (twitch force, specific force, and electrical pacing). ASAIO Journal 2008; 54:284-294.
AB - Tissue engineering strategies are being used to develop functional 3D heart muscle in vitro. Work within our own group has been focused on the development of bioengineered heart muscle using fibrin gel as a support matrix. As tissue engineering models of heart muscle are developed in the laboratory, a critical technologic challenge remains the ability to delivery nutrients to the entire tissue construct. To address this specific need, we have developed a novel perfusion system for cardiac tissue engineering applications. The system consists of a custom microincubator, designed to house ten 35-mm tissue culture plates on independent platforms for controlled fluid delivery and aspiration. Temperature, pH, and media flow rate and oxygenation are all regulated. In the current study, we describe the compatibility of this microperfusion system with bioengineered heart muscles. We demonstrate that the perfusion system is capable of supporting construct viability (mitochondrial activity, total protein, and total RNA) and maintaining contractile properties (twitch force, specific force, and electrical pacing). ASAIO Journal 2008; 54:284-294.
UR - http://www.scopus.com/inward/record.url?scp=46249095575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46249095575&partnerID=8YFLogxK
U2 - 10.1097/MAT.0b013e31817432dc
DO - 10.1097/MAT.0b013e31817432dc
M3 - Article
C2 - 18496279
AN - SCOPUS:46249095575
VL - 54
SP - 284
EP - 294
JO - ASAIO Journal
JF - ASAIO Journal
SN - 1058-2916
IS - 3
ER -